Mechanisms of Nuclear Signalling by Vitamin D3 Interplay with Retinoid and Thyroid Hormone Signalling

European Journal of Biochemistry

Volumn 231, Issue 3, 1995, Pages 517-527

  Carlberg, Carsten ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

gene regulation; model of nuclear hormone signaling; natural vitamin D3 response elements; Nuclear hormone receptors

Indexed keywords

COLECALCIFEROL; HORMONE RECEPTOR; RETINOIC ACID; RETINOID; THYROID HORMONE;

CELL DIFFERENTIATION; DIMERIZATION; HUMAN; MODEL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMAL; BASE SEQUENCE; CELL NUCLEUS; CHOLECALCIFEROL; DNA; HUMAN; LIGANDS; MOLECULAR SEQUENCE DATA; RECEPTORS, CALCITRIOL; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION; SUPPORT, NON-U.S. GOV'T; TRETINOIN; TRIIODOTHYRONINE;

VERTEBRATA;

EID: 0029099609     PISSN: 00142956     EISSN: 14321033     Source Type: Journal    
DOI: 10.1111/j.1432-1033.1995.tb20727.x     Document Type: Review

References (93)

1. the steroid and thyroid hormone receptor superfamily
2. Nuclear receptors enhance our understanding of transcriptional regulation
3. Transcriptional regulation by the nuclear receptor superfamily
4. Steroid and related receptors
5. Evolution of the nuclear receptor gene superfamily
6. Oestrogen and glucocorticoid responsive elements are closely related but distinct
7. Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor
8. The estrogen receptor binds tightly to its responsive element as a ligand‐induced homodimer
9. The thyroid hormone receptor binds with opposite transcriptional effects to a common sequence motif in the thyroid hormone and estrogen response element
10. Retinoic acid and thyroid hormone induce gene expression through a common responsive element
11. 3 receptors
12. 3 receptor
13. 3,5,3′‐Triiodothyronine receptor auxiliary protein (TRAP) enhances receptor binding by interactions within the thyroid hormone response element
14. A 55‐kilodalton accessory factor facilitates vitamin D receptor DNA binding
15. Positive and negative regulation of gene transcription by a retinoic acid‐thyroid hormone receptor heterodimer
16. RXRβ: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements
17. Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently
18. Nuclear receptor that identifies a novel retinoic acid response pathway
19. H‐2RIIBP, a member of the nuclear hormone receptor superfamily that binds to both the regulatory element of major histocompatibilty class I genes and the estrogen response element
20. H‐2RIIBP (RXRβ heterodimerization provides a mechanism for combinatorial diversity in the regulation of retinoic acid and thyroid hormone responsive genes
21. RXRα, a promiscuous partner of retinoic acid and thyroid hormone receptors
22. 3 signalling
23. Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors
24. Flexible friends
25. Promiscuous liaisons
26. Interactions among a subfamily of nuclear hormone receptors: the regulatory zipper model
27. The conserved ninth C‐terminal heptad in thyroid hormone and retinoic acid receptors mediates diverse responses by affecting heterodimer but not homodimer formation
28. The C‐terminal region of the vitamin D receptor is essential to form a complex with a receptor auxiliary factor required for high affinity binding to the vitamin D‐responsive element
29. Determinants for selective RAR and TR recognition of direct repeat HREs
30. Differential orientations of the DNA‐binding domain and carboxy‐terminal dimerization interface regulate binding site selection by nuclear receptor heterodimers
31. The dimerization interfaces formed between the DNA binding domains of RXR, RAR and TR determine the binding specificity and polarity of the full‐length receptors to direct repeats
32. Dimerization interfaces formed between the DNA binding domains determine the cooperative binding of RXR/RAR and RXR/TR heterodimers to DR5 and DR4 elements
33. Homodimer formation of retinoid X receptor induced by 9‐cis retinoic acid
34. 3 response elements
35. Differential DNA binding by monomeric, homodimeric, and potentially heterodimeric forms of the thyroid hormone receptor
36. 3‐receptor homodimers but not receptor‐auxiliary protein heterodimers
37. Two nuclear signalling pathways for vitamin D
38. Interaction between retinoic acid and vitamin D signalling pathways
39. RXR‐independent action of the receptors for thyroid hormone, retinoic acid, and vitamin D on inverted palindromes
40. Specificity and flexibility of vitamin D signalling: modulation of the activation of natural vitamin D response elements by thyroid hormone
41. Identification of a vitamin D receptor homodimer‐type response element in the rat calcitriol 24‐hydroxylase gene promoter
42. 3 receptor (VDR) homodimers into VDR‐retinoid X receptor heterodimers
43. 3 receptor in the absence of the retinoid X receptor
44. 9‐cis retinoic acid is a natural antagonist for the retinoic acid receptor response pathway
45. RXR‐dependent and RXR‐independent transactivation by retinoic acid receptors
46. Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids
47. Characterization of three RXR genes that mediates the action of 9‐cis retinoic acid
48. Cell lines derived from late embryonic stages of Drosophila melanogaster
49. In vivo occupancy of the vitamin D responsive element in the osteocalcin gene supports vitamin D‐dependent transcriptional upregulation in intact cells
50. 3 receptor
51. Characterization of ligand‐dependent phosphorylation of the estrogen receptor
52. Phosphorylation of steroid hormone receptors
53. 3 receptor by cAMP‐dependent protein kinase, in vitro, and in transfected COS‐7 cells
54. Response element selectivity for heterodimerization of vitamin D receptors with retinoic acid and retinoid X receptors
55. 3R heterodimer polarity directs ligand sensitivity of transactivation
56. 3 response elements formed by inverted palindromes: polarity‐directed ligand sensitivity of VDR‐RXR heterodimer‐mediated transactivation
57. Thyroid hormone and retinoic acid receptors form heterodimers with retinoid X receptors on direct repeats, palindromes and inverted palindromes
58. Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers
59. Half‐site spacing and orientation determines whether thyroid hormone and retinoic acid receptors and related factors bind to DNA response elements as monomers, homodimers, or heterodimers
60. Identification of a retinoic acid responsive element in the retinoic acid receptor β gene
61. The orientation and spacing of core DNA‐binding motifs dictate selective transcriptional responses to three nuclear receptors
62. Functional characterization and receptor binding studies of the malic enzyme thyroid hormone response element
63. A direct repeat in the cellular retinol‐binding protein type II gene confers differential regulation by RXR and RAR
64. 3 response element of chicken carbonic anhydrase‐II
65. Thyroid hormone receptor monomers can function as ligand‐inducible transcription factors on octamer sequences: consequences also for heterodimerization
66. Positive and negative thyroid hormone response elements are composed of strong and weak half‐sites 10 nucleotides in length
67. Nonbiased identification of DNA sequences that bind thyroid hormone receptor α1 with high affinity
68. Multiplicity generates diversity in the retinoic acid signalling pathways
69. Specificity and mechanism of thyroid hormone induction from an octamer response element
70. Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding
71. 3: analogs are able to functionally differentiate between nuclear and membrane receptors
72. Retinoid X receptors stimulate and 9‐cis retinoic acid inhibits 1,25‐dihydroxyvitamin Deactivated expression of the rat osteocalcin gene
73. 3 response: hormonal cross talk by ligand‐induced squelching
74. All‐trans and 9‐cis retinoic acid induction of CRABPII transcription is mediates by RAR‐RXR heterodimers bound to DR1 and DR2 repeated motifs
75. Solving the specificity puzzle
76. Vitamin D: New actions, new analogs, new therapeutic potential
77. The mechanisms of vitamin D toxicity
78. Origin of the use of calcipotriol in psoriasis treatment, Rev
79. Immunological properties of vitamin D analogues and metabolites
80. EB 1089, a novel vitamin D analogue, has strong antiproliferative and differentiation inducing effects on cancer cells
81. 3 analogues MC903, EB1089 and KH1060 function as transcriptional activators: vitamin D receptor homodimers show higher ligand sensitivity than heterodimers with retinoid X receptors
82. A dialogue on analogues
83. 3
84. 3
85. 1,25‐dihydroxyvitamin D‐responsive element and glucocorticoid repression in the osteocalcin gene
86. 3 enhancement of mouse secreted phosphoprotein 1 (Spp‐1 or osteopontin) gene expression
87. Characterization of the promoter region of the porcine opn (osteopontin, secreted phosphoprotein 1) gene
88. 3‐response element in the 5′‐flanking region of the rat calbindin D‐9k gene
89. 3
90. 3
91. 3) 24‐hydroxylase gene
92. 3‐ and butyrate‐inducible responses
93. A tissue‐specific enhancer confers Pit‐1‐dependent morphogen inducibility and autoregulation on the pit‐1 gene